IT IS NOT ESTIMATED BY THE END OF DECEMBER, THE STATE OF MARYLAND WILL HAVE ENOUGH DOSES OF A CORONAVIRUS VACCINE TO AT LEAST COVER HEALTH CARE EMPLOYEES. >> WE ARE HOPING TO GET MAYBE 300,000 BY THE END OF DECEMBER AND HOPEFULLY IT IS GOING TO RAMP UP FROM THERE AS PRODUCTION STARTS TO ACCELERATE. >> SPEAKING ON GOOD MORNING AMERICA, GOVERNOR LEE -- GOVERNOR LARRY HOGAN ISSUED THE ORDER OF DISTRIBUTION. HEALTH CARE WORKERS FIRST, THEN NURSING HOMES AND FIRST RESPONDERS AS THE SUPPLY INCREASES. >> WE WILL NEED A PHASED APPROACH BECAUSE WE WILL HAVE INSUFFICIENT NUMBERS OF DOSES TO REACH ALL THOSE WHO SHOWED OR WENT TO GET THE >> VACCINE. EXPERTS FROM THE JOHNS HOPKINS APPEARING BERG SCHOOL OF PUBLIC HEALTH DETAIL THE CHALLENGES AHEAD. STATES MUST COORDINATE DISTRIBUTION AND RESOURCES. THE PFIZER VACCINE REQUIRES ULTRACOLD STORAGE, WHICH PFIZER ITSELF IS TRYING TO SOLVE. >> PFIZER HAS CREATED THESE COLD BOXES THAT CAN STORE ABOUT 5000 VACCINE VIALS. THAT REQUIRES DRY ICE. THAT IS HOW A LOT OF THE PFIZER VACCINE IS GOING TO BE DISTRIBUTED. >> A CRUCIAL BARRIER, PUBLIC ACCEPTANCE OF THE VACCINE. CLEAR AND TRANSPARENT MESSAGING REQUIRED. >> CLINICAL TRIAL PARTICIPANTS FROM THE PFIZER VACCINE TRIAL INDICATED THE VACCINE CAN CAUSE PEOPLE TO FEEL UNWELL FOR A FEW DAYS. WE NEED TO BE ABLE TO COMMUNICATE THIS IS NORMAL AND TO REMIND PEOPLE THE VACCINE HAS UNDERGONE RIGOROUS SAFETY TESTING SHOULD >> THE INITIAL PHASE OF VACCINE SAFETY DEPLOYMENT WILL NOT BE AVAILABLE FOR CHILDREN. THAT MAY COME IN TIME FOR THE NEXT SCHOOL YEAR. >> I AM HOPEFUL BY THE SCHOOL TERM OF FALL OF 2021, WE WILL HAVE A VACCINE THAT WE CAN ADMINISTER TO CHILDREN OVER 12. I THINK WE WILL HAVE A GOOD SHOT OF HAVING A VACCINE FOR EVEN YOUNGER CHILDREN AS WELL. >> TWO IMPORTANT DATES COMING UP. DECEMBER 10, AN ADVISORY GROUP TO THE FDA MEETS IN PUBLIC GO OVER THE DATA FROM PFIZER ABOUT ITS VACCINE AND A WEEK AFTER THAT, SIMILAR PROCESS FOR MODERNITY VACCINE. BOTH THEN SHORTLY EXPECTED AFTER THAT IS THE EMERGENCY USE AUTHORIZATION IF THE FDA GRA
Experts detail challenges ahead as officials develop COVID-19 vaccine distribution plan
Updated: 7:48 AM EST Dec 4, 2020
It's now estimated that Maryland will have enough doses of a coronavirus vaccine by the end of December to at least cover health care employees.|| Coronavirus updates | Maryland's latest numbers | Where to get tested ||Speaking on "Good Morning America," Gov. Larry Hogan listed the planned order of distribution, saying health care workers will get it first, followed by nursing homes and first responders as the supply increases."We are hoping to get 300,000 by the end of December, and then hopefully, it is really going to ramp up from there as production starts to accelerate," Hogan told GMA.During an afternoon briefing, experts from the Johns Hopkins Bloomberg School of Public Health detailed the challenges ahead."We need a phased approach because we will have insufficient numbers of doses to reach all who should or want to get the vaccine," said Dr. William Moss, executive director of the International Vaccine Access Center.States must coordinate distribution and resources. The Pfizer vaccine requires ultra-cold storage, which Pfizer itself is trying to solve."Pfizer itself has created these cold boxes, if you will, that can store about 1,000 to 5,000 vials that requires dry ice. That's how a lot of the Pfizer vaccine will be distributed," Moss said.The experts said public acceptance of a vaccine will be a crucial barrier and that clear and transparent messaging is required."Clinical trial participants from the Pfizer trial indicated the vaccine can cause people to feel unwell for a few days. We need to be able to communicate that this is normal and remind people the vaccine has undergone vigorous testing," Dr. Rupali Limaye, an associate scientist at the Johns Hopkins Bloomberg School of Public Health.The initial phases of vaccine deployment will not be available for children. That might come next year, possibly in time for the next school year."I am hopeful that by the school term of 2021, fall of 2021, we will certainly have a vaccine I think that we could administer to children over 12. I think we will have a good shot of a vaccine for children younger as well," Moss said.Two important dates coming up include Dec. 10, when a U.S. Food and Drug Administration advisory group will hold a public meeting to assess the data from Pfizer's vaccine. A week after that, the same will be done for the vaccine from Moderna. Emergency authorization could come shortly after that.
BALTIMORE — It's now estimated that Maryland will have enough doses of a coronavirus vaccine by the end of December to at least cover health care employees.
|| Coronavirus updates | Maryland's latest numbers | Where to get tested ||
Speaking on "Good Morning America," Gov. Larry Hogan listed the planned order of distribution, saying health care workers will get it first, followed by nursing homes and first responders as the supply increases.
"We are hoping to get 300,000 by the end of December, and then hopefully, it is really going to ramp up from there as production starts to accelerate," Hogan told GMA.
During an afternoon briefing, experts from the Johns Hopkins Bloomberg School of Public Health detailed the challenges ahead.
"We need a phased approach because we will have insufficient numbers of doses to reach all who should or want to get the vaccine," said Dr. William Moss, executive director of the International Vaccine Access Center.
States must coordinate distribution and resources. The Pfizer vaccine requires ultra-cold storage, which Pfizer itself is trying to solve.
"Pfizer itself has created these cold boxes, if you will, that can store about 1,000 to 5,000 vials that requires dry ice. That's how a lot of the Pfizer vaccine will be distributed," Moss said.
The experts said public acceptance of a vaccine will be a crucial barrier and that clear and transparent messaging is required.
"Clinical trial participants from the Pfizer trial indicated the vaccine can cause people to feel unwell for a few days. We need to be able to communicate that this is normal and remind people the vaccine has undergone vigorous testing," Dr. Rupali Limaye, an associate scientist at the Johns Hopkins Bloomberg School of Public Health.
The initial phases of vaccine deployment will not be available for children. That might come next year, possibly in time for the next school year.
"I am hopeful that by the school term of 2021, fall of 2021, we will certainly have a vaccine I think that we could administer to children over 12. I think we will have a good shot of a vaccine for children younger as well," Moss said.
Two important dates coming up include Dec. 10, when a U.S. Food and Drug Administration advisory group will hold a public meeting to assess the data from Pfizer's vaccine. A week after that, the same will be done for the vaccine from Moderna. Emergency authorization could come shortly after that.